Table 2 Comparison of the prognostic value of different models based on gene expression in TNBC
From: ECT2 associated to PRICKLE1 are poor-prognosis markers in triple-negative breast cancer
A PRICKLE1 & GEF/GAP | |||
|---|---|---|---|
MFS,TN BC | Statistic | p value | |
PRICKLE1 | LRX² | 6.23 | 1.25E-02 |
PRICKLE1 + GEF/GAP | LRX² | 8.98 | 1.12E-02 |
GEF/GAP + PRICKLE1 vs. PRICKLE1 | ΔLRX² | 2.75 | 0.097 |
B PRICKLE1 & ECT2 | |||
MFS,TN BC | Statistic | p value | |
PRICKLE1 | LRX² | 6.23 | 1.25E-02 |
PRICKLE1 + ECT2 | LRX² | 11 | 4.14E-03 |
ECT2 + PRICKLE1 vs. PRICKLE1 | ΔLRX² | 4.74 | 2.90E-02 |
